— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -1.6% 1M: -1.4% 3M: -3.2% YTD: +5.4% 1Y: +18.2% 3Y: +63.1% 5Y: +27.6%
$20.91
-0.03 (-0.14%)
 
Weekly Expected Move ±3.5%
$19 $20 $21 $21 $22
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $1.5B mcap · 68M float · 1.19% daily turnover · Short 41% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 15.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.21 (down 99%), Innoviva, Inc. would be worth roughly what it owes.
Total debt $269.7M against a stock market value of $1.51B.
Distance to default 10.31 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $129.2M (short-term plus half of long-term), stock volatility 26.8%; Altman Z'' 9.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$443M
Revenue
+19.8% YoY
$357M
Net Income
+824.3% YoY
$188M
Free Cash Flow
-4.1% YoY
75.8%
Gross Margin
42.5%
Op. Margin
-69.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE36.7%
ROA23.5%
ROIC15.0%

Valuation

P/E4.3
P/B1.2
EV/EBITDA1.8

Leverage

Debt/Equity0.22
Current Ratio16.01
Interest Cov.40.2x

Quality Scores

Piotroski F7/9
Altman Z4.62
Beneish M-1.62

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms